The effects of intraperitoneal and intra-third ventricular administration of morphine on the hypothalamic corticotropin-releasing factor (CRF) and the pituitary-adrenocortical activity were examined in unanesthetized, freely moving rats.
pituitary-adrenocortical activity were examined in unanesthetized, freely moving rats.
Hypothalamic CRF was measured by rat CRF radioimmunoassay. Intraperitoneal or intra-third ventricular administration of morphine increased blood concentrations of ACTH and corticosterone while intraperitoneal administration tended to increase CRF concentration in the whole hypothalamus including the median eminence and intra-third ventricular administration increased CRF concentration in the hypothalamus excluding the median eminence.
However, morphine seemed to inhibit the increase in CRF concentration in the hypothalamus induced by the ether-laparotomy stress. The main site of morphine action on the hypothalamo-pituitary-adrenocortical system seemed to be in the hypothalamic area.
After Nasmyth's (1954) article on adrenal ascorbic acid depletion by morphine, many investigators have reported on the effects of morphine on the pituitary-adrenal system. Since the isolation of the endogenous opioid peptides, enkephalins and endorphins (Hughes et al., 1975; Cox et al., 1975) , much attention has been directed to their roles in regulating pituitary function. Grossman and Besser (1981) have reported that opioids inhibit corticotropinreleasing factor (CRF)-ACTH secretion tonically via the noradrenergic pathway in man. On the other hand, Buckingham and Cooper (1984) have reported that hypothalamic CRF secretion in rats was stimulated after acute systemic administration of morphine in vivo and after morphine or enkephalin administration in vitro in the CRF bioassay system. Recently, Vale et al. (1981) and Rivier et al. (1983) isolated 41-residue ovine and rat CRF, which made possible the development of a radioimmunoassay for CRF. The effects of opioids on the hypothalamo-pituitary-adrenocortical (HPA) system have not been determined by radioimmunoassay of CRF.
In the present study, we examined the effects of acute intraperitoneal and intra-third ventricular administration of morphine on the HPA system in unanesthetized, freely moving rats, using rat CRF radioimmunoassay. 
Results
Experiment I. Effects of intraperitoneal morphine administration on CRF-ACTH-corticosterone activity Hypothalamic CRF concentration tended to increase at 60min after administration of morphine but the response was not statistically significant.
Serum ACTH level was significantly elevated at 60min. Serum corticosterone level was also significantly elevated from 15min to 60min. (Fig. 1) . thalamus. Since the paraventricular nuclei are considered to be the CRF-production site (Sawchenko and Swanson, 1985) , it is suggested that acute administration of morphine stimulates the synthesis of CRF in the hypothalamus. The failure to detect a decrease in CRF concentration in the median eminence after morphine administration seems consistent with the findings of Buckingham (1984) that a single injection of morphine increased CRF content in the hypothalamus in vivo and that morphine increased both the CRF release and the hypothalamic CRF content in vitro using the CRF bioassay. It is not likely that changes in the CRF concentration in the median eminence is a sensitive index for the release of CRF into the portal blood.
Our present results do not neglect the possibility that morphine has a direct effect on the anterior pituitary corticotrophs. However, as several lines of evidence (George and Way, 1959; Lotti et al., 1969; Gibson et al., 1979; Buckingham and Cooper, 1984) show, it is assumed that the opiate has no direct action on the pituitary gland. Recently, we also have found that (D-ala2, met5)-enkephalinamide, a potent methionineenkephalin analog, has no direct effect on the anterior pituitary corticotrophs in pituitary cell cultures (in submission).
As morphine or opioid peptides act on the hypothalamic monoamines, catecholamines (Kuscinsky and Hornykiewicz 1972; Borrell and Borrell 1977; and serotonin (Algeri et al., 1978; Van Loon and De Souza, 1978) , morphineinduced changes in the hypothalamic CRF secretion may be via changes in the hypothalamic monoamines. Furthermore, it is also possible that morphine-induced changes in other ACTH secretagogues (i. e. amines, vasopressin etc.) stimulate ACTH secretion at the pituitary level.
On intraperitoneal administration, the serum corticosterone level was significantly elevated even at 15min after administra-tion, although the serum ACTH level did not show a significant change at 15min. This result obtained by systemic administration may not negate the direct effect of morphine on the adrenal cortex, as Lymangrover et al. (1981) and Meites (1984) have reported that opioids, as well as naloxone, may act directly on the adrenal cortex as well as on the hypothalamus. Briggs and Munson (1955) and Gibson et al., (1979) reported that morphine inhibited the stress-induced ACTH secretion. On the other hand, Buckingham and Cooper (1984) have reported that morphine exaggerated the stress-induced CRF secretion in the hypothalamus and the ACTH secretion from the anterior pituitary in their bioassay system. In our study, if a significant reduction in the hypothalamic CRF concentration in "morphine plus stress" group is due to an excess release of CRF, the ACTH and corticosterone levels must be significantly elevated compared to "morphine alone" and "saline plus stress" groups, as the ACTH and corticosterone levels observed in "morphine alone" and "saline plus stress" groups are not the maximum levels in rats. However, no significant differences were observed between the serum ACTH and corticosterone values for these groups. These results suggest that the hypothalamic CRF reduction in the "morphine plus stress "group is not due to an excess release but due to an inhibition of CRF production.
In summary, our study suggests that an acute administration of morphine stimulates the synthesis of CRF in the hypothalamus, and that, on the other hand, morphine inhibits the CRF production in the hypothalamus induced by the ether-laparotomy stress. The main site of morphine action on the HPA system seems to be in the hypothalamic area.
